These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1662627

  • 41. The regression line for erythromycin is not valid for beta-hemolytic streptococci group A.
    Brorson JE, Larsson P.
    Scand J Infect Dis; 1987; 19(2):243-6. PubMed ID: 3112935
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
    Inouye S, Watanabe T, Tsuruoka T, Kitasato I.
    J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria.
    Goldman RC, Fesik SW, Doran CC.
    Antimicrob Agents Chemother; 1990 Mar; 34(3):426-31. PubMed ID: 2159256
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Potentiation of azithromycin activity against Escherichia coli by human serum ultrafiltrate.
    Pruul H, McDonald PJ.
    J Antimicrob Chemother; 1992 Oct; 30(4):497-507. PubMed ID: 1337068
    [Abstract] [Full Text] [Related]

  • 48. [Sensitivity of clinical bacterial strains to dioxidine in vitro under aerobic and anaerobic conditions].
    Ponomareva TR.
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):199-202. PubMed ID: 3579247
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
    Dunkin KT, Jones S, Howard AJ.
    J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
    [Abstract] [Full Text] [Related]

  • 51. Synthesis and antibacterial activity of O-methylazithromycin derivatives.
    Kobrehel G, Lazarevski G, Dokić S, Kolacny-Babić L, Kucisec-Iepes N, Cvrlje M.
    J Antibiot (Tokyo); 1992 Apr; 45(4):527-34. PubMed ID: 1317368
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.
    Girard AE, Girard D, Retsema JA.
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():61-71. PubMed ID: 2154439
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Clinical laboratory approach for estimating effective administrative dose of cefuzonam. Evaluation of disc susceptibility test and its interpretation system].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Oct; 41(10):1407-17. PubMed ID: 3204654
    [Abstract] [Full Text] [Related]

  • 56. [In vitro activity of imipenem against hospital bacteria].
    Soussy CJ, Duval J.
    Presse Med; 1990 Apr 04; 19(13):583-7. PubMed ID: 2139936
    [Abstract] [Full Text] [Related]

  • 57. Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.
    Dalhoff A, Stubbings W, Schubert S.
    Antimicrob Agents Chemother; 2011 Apr 04; 55(4):1814-8. PubMed ID: 21245444
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
    Robbins MJ, Marais R, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1987 Apr 04; 13(9):551-4. PubMed ID: 2962846
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.